Helen Rubenstein
Vice President, Investor Relations
Replay available
Neumora Therapeutics, Inc. (NMRA) Q3 2024 Earnings Call
Neumora Therapeutics, Inc. (NASDAQ: NMRA) Q3 2024 earnings conference call, held 2024-11-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Henry Vosabrook
President and Chief Executive Officer
Josh Pinto
Chief Financial Officer
Rob Lenz
Head of Research and Development
Brian Abrahams
Analyst, RBC Capital Markets
Miles Minter
Analyst, William Blair
Charles Alford Gray
Analyst, Mizuho
Douglas Sao
Analyst, HC Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neumora Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.109 -- 00:00:02.471 Ladies and gentlemen, thank you for standing by. 00:00:02.471 -- 00:00:05.654 At this time, all participants are in a listen-only mode. 00:00:05.654 -- 00:00:09.477 After the speaker's presentation, there will be a question-and-answer session. 00:00:09.477 -- 00:00:12.800 Please be advised that today's conference is being recorded. 00:00:12.800 -- 00:00:17.543 I would now like to turn the conference over to Helen Rubenstein, Vice President of Investor 00:00:17.543 -- 00:00:20.925 Relations. Please go ahead. 00:00:22.548 -- 00:00:26.971 Good morning, and thank you for joining me more at Therapeutics' third quarter 2024 Financial 00:00:26.971 -- 00:00:31.323 Results Conference Call. Before we begin, I encourage everyone to go to the Investors 00:00:31.323 -- 00:00:34.926 and Media section of our website at numorotx.com, 00:00:34.926 -- 00:00:38.189 where you can find the press release related to today's call. 00:00:38.189 -- 00:00:42.832 With me today are President and Chief Executive Officer Henry Vosabrook and Chief Financial 00:00:42.832 -- 00:00:47.756 Officer Josh Pinto. Head of Research and Development Rob Lenz will join us for the Q&A 00:00:47.756 -- 00:00:52.119 portion of the call. I'd like to point out that we'll be making forward-looking statements, 00:00:52.119 -- 00:00:55.142 which are based on our current expectations and beliefs. 00:00:55.142 -- 00:00:59.337 These statements are subject to certain risks and uncertainties, and our actual results 00:00:59.337 -- 00:01:03.698 may differ materially. Please review the risk factors discussed in today's press release 00:01:03.698 -- 00:01:06.699 and in our SEC filings for additional details. 00:01:06.699 -- 00:01:10.300 With that, I'll now turn the call over to Henry. 00:01:1...